In Hee Kim
Overview
Explore the profile of In Hee Kim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
125
Citations
1366
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Lee C, Kang H, Yu S, Seo S, Kim S, Kim S, et al.
Sci Rep
. 2023 Apr;
13(1):6067.
PMID: 37055466
This study aimed to investigate the initial treatment response and short-term mortality of spontaneous bacterial peritonitis (SBP) in cirrhotic patients with hepatocellular carcinoma (HCC) compared with those without HCC. A...
22.
Kim J, Kim Y, Yi S, Kim I, Kang M, Kim D
Spine Surg Relat Res
. 2023 Apr;
7(2):179-182.
PMID: 37041878
Introduction: The strut iliac bone graft has been widely used to achieve fusion in various anterior cervical spinal surgeries but some complications often remain, such as pain and gross deformity....
23.
Kim K, Lee S, Park H, Jang E, Lee Y, Bum Cho S, et al.
Clin Mol Hepatol
. 2023 Mar;
29(2):496-509.
PMID: 36880209
Background/aims: We used next-generation sequencing (NGS) to analyze resistance-associated substitutions (RASs) and retreatment outcomes in patients with chronic hepatitis C virus (HCV) infection who failed direct-acting antiviral agent (DAA) treatment...
24.
Choi G, Jang E, Kim Y, Lee Y, Kim I, Bum Cho S, et al.
World J Gastroenterol
. 2022 Sep;
28(30):4182-4200.
PMID: 36157119
Background: Prospective studies of the long-term outcomes of patients with hepatitis C virus (HCV) infection after treatment with interferon-based therapy (IBT) or direct-acting antivirals (DAA) are limited in many Asian...
25.
Kim H, Kim J, Yeon J, Seo Y, Jang J, Cho Y, et al.
J Korean Med Sci
. 2022 Mar;
37(11):e92.
PMID: 35315603
Background: Tenofovir disoproxil fumarate (TDF, Viread) had been used as a standard treatment option of chronic hepatitis B (CHB). This clinical trial was conducted to evaluate the efficacy and safety...
26.
Kim K, Choi G, Jang E, Kim Y, Lee Y, Kim I, et al.
Epidemiol Health
. 2021 Oct;
43:e2021077.
PMID: 34645207
Objectives: Injection drug use is a major risk factor for hepatitis C virus (HCV) infection; however, limited data on this topic are available in Korea. Thus, this study aimed to...
27.
28.
Cho Y, Yu S, Lee H, Kim D, Kang W, Paik Y, et al.
J Hepatocell Carcinoma
. 2021 Jun;
8:613-623.
PMID: 34169044
Background/aim: Sorafenib is the first systemic therapy for the treatment of advanced-stage hepatocellular carcinoma (HCC) and progressive HCC after locoregional therapy. The aim of this study was to evaluate the...
29.
30.
Yim S, Kim K, Lee C, Song E, Lee S, Kim S, et al.
In Vivo
. 2021 Apr;
35(3):1485-1497.
PMID: 33910826
Background/aim: Intestinal mucositis with diarrhea is a dose-limiting toxicity of 5-fluorouracil (5-FU). M40403, a superoxide dismutase mimetic, was evaluated on whether it improves the mucositis with diarrhea. Materials And Methods:...